...
首页> 外文期刊>Journal of neurosurgery. >Intracranial aneurysms treated with the Guglielmi detachable coil: midterm clinical results in a consecutive series of 100 patients.
【24h】

Intracranial aneurysms treated with the Guglielmi detachable coil: midterm clinical results in a consecutive series of 100 patients.

机译:用Guglielmi可拆卸线圈治疗颅内动脉瘤:连续100例患者的中期临床结果。

获取原文
获取原文并翻译 | 示例
           

摘要

A prospective study was designed to evaluate clinical outcome in a series of 100 consecutively treated patients who underwent endovascular embolization of 104 intracranial aneurysms using Guglielmi detachable coils (GDCs). Midterm clinical outcome (2-6 years, average 3.5 years) was obtained for 94 patients and was classified according to a modified Glasgow Outcome Scale. Of nine patients treated in the acute phase of severe subarachnoid hemorrhage (Grade IV or V), seven died from the initial hemorrhage, one had a poor outcome, and one had a fair midterm outcome, with no post-GDC embolization hemorrhages. Twenty patients underwent subsequent surgical or endovascular procedures that did not include the use of GDCs. These included aneurysm clipping in nine patients and parent vessel sacrifice in 11 patients. None of these 20 patients experienced post-GDC embolization hemorrhage. The postoperative midterm clinical outcomes of these 20 patients did not significantly differ from the outcomes of patients who underwent GDC embolization as their definitive treatment. Six patients died of unrelated causes prior to reaching the 2-year survival point, with no post-GDC embolization hemorrhage. The midterm outcomes of the remaining 61 patients who underwent GDC embolization as their definitive treatment were classified as excellent (46 patients [75%]), good (seven patients [11%]), fair (three patients [5%]), poor (one patient [2%]), or dead (four patients [7%]). All four patients died from giant lesions. At midterm follow up, the surviving 57 patients' neurological statuses were unchanged or improved in 54 cases and worsened in three cases. The midterm post-GDC embolization hemorrhage rate was 0% for small aneurysms, 4% (one case) for large aneurysms, and 33% (five cases) for giant lesions. The GDC procedure is a safe, effective, and reliable means of preventing aneurysm hemorrhage in patients with small and large intracranial aneurysms. Results, however, are less satisfactory in cases involving giant lesions. Further follow-up review is necessary to establish durability in the longer term. Patients with Grade IV or V subarachnoid hemorrhage in this series generally had poor outcomes even if the GDC procedure was successful in occluding the aneurysm.
机译:设计了一项前瞻性研究,以评估使用Guglielmi可分离线圈(GDC)对104例颅内动脉瘤进行血管内栓塞的100例连续接受治疗的患者的临床结局。 94例患者获得了中期临床结局(2-6年,平均3。5年),并根据改良的格拉斯哥成果量表进行了分类。在严重的蛛网膜下腔出血(IV级或V级)急性期接受治疗的9例患者中,有7例死于最初的出血,1例预后较差,1例中期尚可,无GDC栓塞后出血。 20名患者随后接受了不包括使用GDC的手术或血管内手术。这些措施包括9例患者的动脉瘤夹闭和11例患者的父母血管牺牲。这20例患者均未发生GDC栓塞后出血。这20例患者的术后中期临床结局与接受GDC栓塞作为最终治疗的患者的结局没有显着差异。 6名患者在达到2年生存点之前死于无关原因,没有发生GDC栓塞后出血。其余61例接受GDC栓塞作为最终治疗的患者的中期结局分为:优秀(46例[75%]),良好(7例[11%]),一般(3例[5%]),差(一名患者[2%])或死亡(四名患者[7%])。所有四名患者均死于巨大病变。在中期随访中,有54例存活的57例患者的神经系统状况没有改变或有所改善,有3例恶化了。 GDC中期栓塞后出血的小动脉瘤率为0%,大动脉瘤为4%(1例),巨灶为33%(5例)。 GDC程序是一种预防颅内动脉瘤大小的患者的安全,有效和可靠的方法。然而,在涉及巨大病变的病例中,结果并不令人满意。为了建立长期的持久性,有必要进行进一步的随访检查。即使GDC手术成功阻塞了动脉瘤,该系列IV级或V级蛛网膜下腔出血患者的预后也较差。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号